MetaCap

Biote (BTMD) vs Glass House Brands Subordinate Voting Shares (GLAS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Biote (BTMD) has outperformed Glass House Brands Subordinate Voting Shares (GLAS) over the past year, losing 68.9% versus a loss of 81.8%. Over five years, GLAS leads with a -73.3% price change compared with -91.6% for BTMD. Glass House Brands Subordinate Voting Shares is the larger company by market cap ($118.1 million vs $26.3 million), about 4.5 times the size, while Biote is growing revenue faster (-2.5% vs -9.4%).

Biote converts more of its revenue into profit, with a net margin of 14.1% versus -16.3%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BTMD-68.90%GLAS-81.82%
+119%+14%-91%
Nov 21, 20251 yearNov 20, 2026
BTMD-91.64%GLAS-74.07%
+213%+53%-106%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BTMD versus GLAS key metrics
MetricBTMDGLAS
Share price$0.8147$1.18
Market cap$26.28M$118.11M
1-day change-3.56%-2.48%
YTD return-68.67%-86.67%
1-year return-68.90%-81.82%
5-year return-91.64%-73.33%
Forward P/E3.33—
EPS (TTM)$-0.07$-0.69
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$192.22M$181.98M
Revenue growth (YoY)-2.52%-9.41%
Net income (latest FY)$27.05M$-29.66M
Gross margin71.46%42.29%
Operating margin18.50%-9.08%
Net margin14.07%-16.30%
52-week high$2.90$13.93
52-week low$0.81$1.06
Distance from 52-week high-71.91%-91.53%
Analyst consensusnonestrong_buy
Avg. price target upside+220.36%+465.25%
Average volume146.21K2.02M
Shares outstanding27.04M93.85M
Employees223357
SectorHealth CareHealth Care
Industry Medicinal Chemicals and Botanical Products Medicinal Chemicals and Botanical Products

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Glass House Brands Subordinate Voting Shares is about 4.5 times larger than Biote by market value ($118.11M vs $26.28M).
  • BTMD has outperformed GLAS by 12.9 percentage points over the past year.
  • Biote is more profitable, keeping 14.1 cents of every revenue dollar as net income versus -16.3 cents for Glass House Brands Subordinate Voting Shares.
  • Biote grew revenue faster in its latest fiscal year (-2.52% vs -9.41%).

About Biote

BTMD stock →

biote Corp. operates in practice-building business within the hormone optimization space.

Health Care · Medicinal Chemicals and Botanical Products · 223 employees

About Glass House Brands Subordinate Voting Shares

GLAS stock →

Glass House Brands Inc., together with its subsidiaries, operates as an integrated cannabis company in the United States. It operates through three segments: Retail; Wholesale Biomass; and Cannabis-Related Consumer Packaged Goods.

Health Care · Medicinal Chemicals and Botanical Products · 357 employees

BTMD vs GLAS FAQ

Which is bigger, Biote or Glass House Brands Subordinate Voting Shares?

Glass House Brands Subordinate Voting Shares (GLAS) is larger, with a market capitalization of $118.11M compared with $26.28M for Biote (BTMD).

Which stock has performed better over the past year, BTMD or GLAS?

BTMD returned -68.90% over the past 12 months, compared with -81.82% for GLAS (price return, excluding dividends). Past performance does not predict future results.

Are Biote and Glass House Brands Subordinate Voting Shares in the same industry?

Yes. Both are classified in the Medicinal Chemicals and Botanical Products industry within the Health Care sector.

More comparisons